You are here

  • Home
  • Archive
  • Volume 9, Issue 9
  • Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab

 

Online download statistics by month:

Online download statistics by month: September 2021 to August 2024

AbstractFullPdf
Sep 2021874879246
Oct 2021350350107
Nov 202123924159
Dec 202123423563
Jan 202215315839
Feb 202210310542
Mar 202214715047
Apr 202213013146
May 202213613645
Jun 202216917424
Jul 202212712823
Aug 202215615729
Sep 202214914930
Oct 202214114337
Nov 202211111140
Dec 2022878733
Jan 2023979920
Feb 2023969615
Mar 2023959733
Apr 2023777720
May 2023737416
Jun 2023757516
Jul 2023717121
Aug 202362639
Sep 2023717115
Oct 2023515119
Nov 2023636521
Dec 2023959624
Jan 2024464825
Feb 2024707034
Mar 2024525286
Apr 2024535328
May 2024242418
Jun 2024373618
Jul 2024727330
Aug 2024414319
Total462746681397